FIELD: biotechnology.
SUBSTANCE: invention relates to versions of keratin and can be used in medicine when producing a drug having antipyretic, analgesic, antitussive, expectorant, anticonvulsant and antiepileptic action.
EFFECT: invention provides the therapeutic use of keratin, having efficacy in reducing a rise in body temperature in a fever model in SD rats and prolonging the latency of seizures in class II, class III and class IV epilepsy in mice; expectorant action in method with release of phenol red in mice; antitussive action in the method of stimulating cough with the help of aqueous ammonia solution in mice, a tendency to reduce the number of writhings in mice and potential analgesic action in acetic acid-induced writhings in ICR mice.
10 cl, 3 dwg, 9 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| KERATIN BD-11, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825992C1 |
| KERATIN BD-13, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825991C1 |
| KERATIN BD-3, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2815384C1 |
| KERATIN BD-1, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825994C1 |
| KERATIN BD-10, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2823655C1 |
| KERATIN BD-4, PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF | 2020 |
|
RU2824893C1 |
| ANTI-MESOTHELIN ANTIBODY AND CONJUGATE THEREOF WITH MEDICINAL PRODUCTS | 2019 |
|
RU2747995C1 |
| PROTEIN AND VACCINE AGAINST SARS-CoV-2 INFECTION | 2020 |
|
RU2815060C1 |
| THERAPEUTIC BIOPREPARATION FOR TREATING HEPATOCELLULAR CARCINOMA | 2014 |
|
RU2739218C2 |
| NEW MONOCLONAL ANTIBODIES TO PROGRAMMED CELL DEATH 1 (PD-1) PROTEIN | 2016 |
|
RU2757316C2 |
